Page last updated: 2024-08-23
alovudine and palbociclib
alovudine has been researched along with palbociclib in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Affolter, T; Buckman, D; Christensen, JG; Cullinane, C; Fahey, NR; Kuszpit, K; Lappin, PB; Li, W; Lira, ME; Nichols, T; O'Brien, P; Painter, CL; Spilker, M; Wong, A; Yan, Z; Zasadny, K; Zhang, CC; Zhang, Q | 1 |
Other Studies
1 other study(ies) available for alovudine and palbociclib
| Article | Year |
|---|---|
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Proliferation; Cyclin-Dependent Kinases; Dideoxynucleosides; Disease Models, Animal; Humans; Mice; Mice, Nude; Mice, SCID; Neoplasms; Piperazines; Positron-Emission Tomography; Pyridines; Thymidine; Xenograft Model Antitumor Assays | 2012 |